-75%

est. 2Y upside i

HealthcareFinTechSeries B

A leading digital bank in the US offering personal and business…

Rank

#2607

Sector

Healthtech, Fintech, Digital Wellness

Est. Liquidity

~4Y

Data Quality

Data: Low

Oxygen presents a high-risk, moderate-upside equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (15%)+300%

Oxygen successfully executes its pivot, securing key partnerships with alternative health plan providers and rapidly acquiring self-employed individuals and small businesses. Its unique health-integrated financial platform gains significant traction, driving revenue to $150M+ by 2028 and justifying a $400M+ valuation (4x current estimated valuation) at exit, providing substantial returns for common shareholders.

Base (40%)+75%

Oxygen gains moderate traction in the niche of health-integrated financial solutions, but faces strong competition and slower-than-anticipated customer acquisition. It achieves modest growth, reaching approximately $50M in revenue by 2028 and a $175M valuation, offering a reasonable but not transformative return for common stock after accounting for preferences.

Bear (45%)-90%

The pivot struggles to find product-market fit or scale customer acquisition amidst high regulatory hurdles and intense incumbent competition. Further funding becomes challenging, leading to a down round or acquisition at a distressed valuation (e.g., $50M or less), resulting in minimal to no recovery for common shareholders due to the significant liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Investors hold $37M in liquidation preferences ahead of common stock. If the company exits at or below $37M, common shareholders will receive nothing.

Dilution Risk

high

Given the recent pivot and the need to fund a new business model, significant future funding rounds are likely, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

As a Series B company undergoing a major strategic pivot, there is currently no active secondary market or tender offer for employee equity.

Other — 6 roles

View all 6 open roles at Oxygen →

Last updated: February 17, 2026

Questions to Ask at the Interview

Strategic questions based on Oxygen's data — designed to show you've done your homework.

  • 1

    “Given the significant pivot from digital banking to health-integrated financial solutions, how is Oxygen addressing the challenge of re-acquiring and building trust with a new customer base, especially after closing existing accounts?”

  • 2

    “The healthtech and fintech sectors both have high regulatory barriers and dominant incumbents. What specific strategies is Oxygen implementing to build a defensible competitive moat in this new, combined space, particularly against large players like UnitedHealth or established financial institutions?”

  • 3

    “With $37M in total funding and a recent Series B, how does the company envision its next funding round, and what milestones are critical to achieving a valuation that provides meaningful returns for common shareholders, especially considering the severe preference stack?”

Community

Valuation Sentiment

Our model estimates -75% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.